Gender-affirming hormone and puberty blocker use increased in Norway from 2008 to 2022
Norway saw increased use of gender-affirming hormones and blockers since 2015
A nationwide register-based study in Norway from 2008 to 2022 found that incidence of gender incongruence diagnoses and prevalence of gender…
Since 2015, more teens in Norway received gender-affirming hormones and puberty blockers, while diagnoses for gastrointestinal issues also r…
Letrozole protocol associated with higher live birth and lower adverse outcomes versus estrogen-progesterone in ovulation disorder FET
Letrozole Prep Boosts Live Births, Lowers Risks
This single-center retrospective cohort study compared ovulation induction using Letrozole against an artificial programmed protocol using e…
Women with ovulation issues who take Letrozole before frozen embryo transfers have higher live birth rates and lower risks of miscarriage an…